Plantar Warts (Verruca Plantaris, Refractory)

Patient Summary

Is this FDA-cleared for this use?

Not FDA-cleared for plantar warts (verruca plantaris). FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.

What evidence exists?

Tier C (investigational). Anecdotal only. Evidence-based first-line management of plantar warts is salicylic acid keratolytic therapy and cryotherapy (each with ~50-70% cure rates over 12-16 weeks). Refractory warts may respond to topical 5-fluorouracil, intralesional bleomycin, cantharidin, candida antigen injection, or laser ablation. Many plantar warts also resolve spontaneously over 12-24 months.

Main risks

• Bleeding from each bite site for 6 to 10 hours after the leech detaches
• Iron-deficiency anemia from cumulative blood loss across multiple sessions
• Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
• Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
• Permanent Y-shaped bite-mark scars or hyperpigmentation at attachment sites
• Local pain, bruising, swelling, or itching for 1 to 3 days after each session
• Spread of HPV to surrounding skin from disturbing the wart surface
• Painful prolonged bleeding from a thick keratinized plantar surface that does not seal easily

Who should not consider this

• Patients with diabetes, peripheral arterial disease, or peripheral neuropathy (high foot-ulcer risk)
• Patients whose warts have not had a proper trial of salicylic acid, cryotherapy, or other standard therapy
• Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, heparin, or daily aspirin used for medical reasons
• People with hemophilia or any other inherited bleeding disorder
• Patients with severe anemia (hemoglobin under 10 g/dL)
• People with an active infection at the planned application site
• Patients who are pregnant or breastfeeding (relative contraindication; insufficient safety data)

What to ask your clinician

• Have I tried salicylic acid for at least 12 weeks?
• Have I tried cryotherapy for 2-3 sessions?
• Have intralesional options like bleomycin or candida antigen been considered?
• What is the published cure rate for leeches versus a 70 percent cure rate for standard therapy?
• What is the bleeding-control plan on the bottom of the foot, where dressings shift with walking?
• How will viral spread to other foot skin be prevented?

When to seek urgent care

• Bleeding from a bite site that soaks through more than one dressing per hour
• Bleeding that continues more than 24 hours after the leech detached
• Spreading redness, warmth, swelling, pus, or red streaks around any bite site
• Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
• Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
• Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
• Inability to bear weight on the foot due to pain or new wound
• Spreading streaks of redness up the foot or leg